MZO · Class II · 21 CFR 866.3169

FDA Product Code MZO: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus

Leading manufacturers include Roche Diagnostics and Abbott Laboratories.

2
Total
2
Cleared
239d
Avg days
2023
Since
Stable submission activity - 1 submissions in the last 2 years
Review times increasing: avg 270d recently vs 208d historically

FDA 510(k) Cleared Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus Devices (Product Code MZO)

2 devices
1–2 of 2

About Product Code MZO - Regulatory Context

510(k) Submission Activity

2 total 510(k) submissions under product code MZO since 2023, with 2 receiving FDA clearance (average review time: 239 days).

Submission volume has remained relatively stable over the observed period, with 1 submissions in the last 24 months.

FDA Review Time

Recent submissions under MZO have taken an average of 270 days to reach a decision - up from 208 days historically. Manufacturers should account for longer review timelines in current project planning.

MZO devices are reviewed by the Microbiology panel. Browse all Microbiology devices →